Category: Treatment


Stage 4 Mucosal Melanoma to No Evidence of Disease: Dane Thorp's Journey

By Renee Orcione, MRA Digital Engagement & Communications Manager | 26 June 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Science, Treatment

“I can’t hide the fact that I had melanoma,” said Stage 4 mucosal melanoma survivor Dane Thorp. “And when I share my story with others, I always emphasize the importance of being your own advocate.”

Read More


What to Know About the Different Types of Cutaneous Melanoma

21 June 2024 In Allies & Partnerships, Prevention, Science, Treatment

Cutaneous melanoma is the most common form of melanoma, accounting for roughly 90% of all diagnoses. Cutaneous melanoma typically develops on skin that receives UV exposure. Other types of melanoma include acral, uveal, and mucosal melanoma – these are known as rare melanoma subtypes and are not believed to be...

Read More


AI and Melanoma: Innovation for the Future

17 June 2024 In Allies & Partnerships, Prevention, Science, Treatment

“Artificial intelligence (AI) is going to transform how we diagnose, treat, and eventually overcome melanoma,” says Dr. Veronica Rotemberg, Director, Dermatology Imaging Informatics Program at Memorial Sloan Kettering Cancer Center.

Read More


Melanoma Awareness Month 2024: In Case You Missed It

By Renee Orcione, MRA Digital Engagement & Communications Manager | 30 May 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment

Throughout the last 31 days, the entire melanoma community has come together to recognize Melanoma Awareness Month. The community heard from leading experts in the field, connected with other patient advocates, and spread awareness of melanoma and the importance of prevention, early detection, and the impact of research. 

Read More


Kelly McWhinney's Melanoma Journey of Perseverance and Perspective

By Renee Orcione, MRA Digital Engagement & Communications Manager | 13 May 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Science, Treatment

In March of 2022, Kelly McWhinney was a busy mother to her one and two-year-old daughters Mia and Blakely. Life was as hectic as expected for the 27-year-old, but when she noticed that a mole on her back was suddenly changing, she decided to call her dermatologist.

Read More


Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Research

1 May 2024 In Allies & Partnerships, News, Prevention, Science, Treatment

The Melanoma Research Alliance (MRA), the world’s leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe. Melanoma, the deadliest form of skin cancer, remains a public...

Read More


Melanoma Awareness Month: Ways to Get Involved

By Renee Orcione, MRA Digital Engagement & Communications Manager | 29 April 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment

Melanoma Awareness Month, held each May, is an occasion to connect and be in community with others who have been touched by melanoma. With this month brings the opportunity to join forces with other melanoma advocates to raise awareness of melanoma research, the importance of early detection, and the many...

Read More


Why I Step – Jeff Heaser

By Renee Orcione, MRA Digital Engagement & Communications Manager | 18 April 2024 In Allies & Partnerships, Events, Melanoma Stories, Prevention, Science, Treatment

In the summer of 2017, Jeff Heaser's eldest son, Jake, received a devastating diagnosis: Stage 4 melanoma. Over the following several years to treat his melanoma, Jake underwent multiple surgeries, radiation treatment, BRAF targeted therapy, immunotherapy, and countless blood tests and scans through Vanderbilt-Ingram Cancer Center.

Read More


Neoadjuvant Therapy and the Melanoma Standard of Care: Where Does it Fit In?

15 April 2024 In Allies & Partnerships, Science, Treatment

The standard of care for patients with high-risk Stage 3 melanoma with active disease, palpable lymph nodes (lymph nodes that can be felt), or in-transit metastasis (cancer cells that have started to spread but have not yet reached the lymph nodes)1 is surgery followed by systemic treatment.

Read More


What Melanoma Patients Need to Know About AMTAGVI

By Renee Orcione, MRA Digital Engagement & Communications Manager | 28 March 2024 In News, Science, Treatment

You may have heard of AMTAGVI, also known by the generic name lifileucel, a new therapy that recently earned FDA approval. AMTAGVI is a type of cellular therapy that uses Tumor Infiltrating Lymphocytes (TILs) to treat patients with advanced melanoma whose melanoma hasn’t responded – or quit responding – to PD-1 based immunotherapies and BRAF/MEK targeted therapy if their melanoma has the BRAF mutation.

Read More


Login

×